Next Article in Journal
Trifarotene: A Current Review and Perspectives in Dermatology
Next Article in Special Issue
The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
Previous Article in Journal
Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia
Previous Article in Special Issue
Monoassociation of Preterm Germ-Free Piglets with Bifidobacterium animalis Subsp. lactis BB-12 and Its Impact on Infection with Salmonella Typhimurium
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Potential Relevance of the Microbiome to Hair Physiology and Regeneration: The Emerging Role of Metagenomics

1
Charité-Universitatsmedizin Berlin, Corporate Member of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin, Clinical Research Center for Hair and Skin Science, Department of Dermatology, Venereology and Allergy, Charitéplatz 1, 10117 Berlin, Germany
2
Bioinformatics ERA Chair, The Cyprus Institute of Neurology and Genetics, 6 Iroon Avenue, 2371 Ayios Dometios, Nicosia, Cyprus
*
Author to whom correspondence should be addressed.
Submission received: 31 January 2021 / Revised: 22 February 2021 / Accepted: 23 February 2021 / Published: 26 February 2021
(This article belongs to the Special Issue Microbial Ecology in Health and Disease)

Abstract

:
Human skin and hair follicles are recognized sites of microbial colonization. These microbiota help regulate host immune mechanisms via an interplay between microbes and immune cells, influencing homeostasis and inflammation. Bacteria affect immune responses by controlling the local inflammatory milieu, the breakdown of which can result in chronic inflammatory disorders. Follicular microbiome shifts described in some inflammatory cutaneous diseases suggest a link between their development or perpetuation and dysbiosis. Though the hair follicle infundibulum is an area of intense immunological interactions, bulb and bulge regions represent immune-privileged niches. Immune privilege maintenance seems essential for hair growth and regeneration, as collapse and inflammation characterize inflammatory hair disorders like alopecia areata and primary cicatricial alopecia. Current research largely focuses on immunological aberrations. However, studies suggest that external stimuli and interactions across the follicular epithelium can have profound effects on the local immune system, homeostasis, and cycling. Herein, we review hair follicle bacterial colonization, its possible effects on the underlying tissue, and links to the pathogenesis of alopecia, beyond the pure investigation of specific species abundance. As skin microbiology enters the metagenomics era, multi-dimensional approaches will enable a new level of investigations on the effects of microorganisms and metabolism on host tissue.

Graphical Abstract

1. Introduction

The surface of human skin is a site of microbial colonization [1,2]. The commensal flora of the skin maintain a symbiotic relationship and shape the cutaneous immunity of the host [3,4]. Several studies have characterized the cutaneous bacterial communities of healthy individuals and patients with inflammatory diseases, mostly in material collected using swabs [5,6,7,8,9]. Such sampling from hair follicle (HF) openings, however, is especially challenging. Along their epithelium, HFs harbor a multitude of microorganisms able to reach deeper compartments [10], frequently organized in biofilms [11,12]. As only few animal models allow to address scientific questions related to those events, hair research largely relies on patient samples, i.e., biopsies, though hair plucking is increasingly used [11,13]. While the role of bacteria as disease-aggravating factors has been recognized for HF-associated inflammatory diseases such as acne vulgaris or folliculitis decalvans [12,14,15], only scarce information is available on how changes in the follicular microbial communities can affect HF immunology, cycling, and regeneration.

2. Bacterial and Host Crosstalk

There is increasing proof of the presence of bacteria reaching below the skin surface and along the HFs [10,11,16], and rising evidence is emerging that the cross-talk between bacteria and the underlying tissue is a dynamic reciprocal process [17,18]. External microbial stimuli create immunological responses across the HF epithelium [19], but events in the tissue also shape microbial composition [12]. Along the infundibular HF epithelium, microorganisms find themselves in a highly immuno-active environment. Their presence triggers innate immune responses via the induction of antimicrobial peptides and cytokines [20,21], but this specific anatomic niche further provides access to antigen-presenting cells [22,23] and sets the ground for immunomodulatory interactions with wider implications for tissue homeostasis and regeneration.
HF morphogenesis, commensal microbe colonization, and local chemokine production work in concert to establish a regulatory T cell (T-regs) niche early in life [24]. Additionally, HFs appear to be crucial for tissue-immune crosstalk, but they depend on macrophage for quorum sensing induced regeneration [25], T-regs for HF stem cell differentiation [26], and innate lymphoid cells for sebaceous gland control [27]. Innate lymphoid cells in the vicinity of the sebaceous gland affect sebaceous gland function and microbial commensals by producing cytokines and growth factors that promote barrier function and the expulsion of pathogens [27].

3. Hair Follicle Immune Privilege and Disease

Anatomic sites of immune privilege (IP) can be found in the brain, eyes, gonads, and skin, and provide a microenvironment which restricts immune-mediated inflammation, e.g., by suppression of antigen-recognition pathways [28,29]. Various mechanisms determine IP including confluence of cells, cellular factors, architectural barriers, or the absence of lymphatic drainage [29]. However, IP development is a dynamic process that, in order to be sustained, often requires only a subset of these mechanisms, resulting in a “relative” IP status with a particular degree of immune protection [28].
As for the HF, the bulb and bulge region display a characteristic downregulation of major histocompatibility complex (MHC) class I and II expression [30,31]. As well as local expression of immunoregulatory and immunosuppressive factors, including proopiomelanocortin-derived neuropeptide (α-MSH), members of growth factor family (TGF-β1, IGF-1) and mediators like the macrophage migration inhibitory factor that actively suppresses NK cell responses [30,31]. Once established, IP remains a dynamic state [32]. Restoration of the bulb IP during the anagen phase is essential to maintain hair growth [33,34]. Impairment of IP maintenance has been associated with pathogenesis and perpetuation of inflammatory hair disorders [35]. Based on the marked peribulbar inflammatory infiltrate of anagen HFs in alopecia areata (AA), the collapse of the bulb IP is believed to be a central event in the inflammatory destruction and subsequent inability to regrow hair during active flare-ups [36,37].
Similar to the findings in the bulb, characteristics of a relative IP including decreased cell-surface markers and β-2-microglobulin, as well as increased CD200 (an immunoregulatory glycoprotein) were found in the bulge region [38,39], which harbors epithelial stem cells essential for HF regeneration. Based on those findings, the concept of IP breakdown was extended to primary cicatricial alopecias (PCA), e.g., lichen planopilaris, which primarily involves inflammatory infiltration and subsequent destruction of the bulge region [35,40,41]. However, it is unclear whether IP collapse occurs early in the disease process before inflammation develops or later as a secondary phenomenon [35].

4. Could External Factors Negatively Impact IP Maintenance?

Considering the multitude of microorganisms residing in follicular openings, the question arises whether external factors could impact the immunological activation state of the underlying tissue, thereby facilitating the disruption of the local IP. Anatomically, the infundibulum would be the most obvious site for such interactions. This rather superficial compartment has long been recognized as a site of intense immune cell trafficking and activation [42], but also pathogen invasion, as observed in ostiofolliculitis [43]. The barrier function of the epithelium is less developed in deeper parts, which increases the likelihood of tissue penetration for exogenous compounds, including larger molecules such as nucleic acids, proteins, particles, and viruses [44,45,46]. Penetration studies point towards an enhanced penetration and a special vulnerability of the HF during the anagen phase of the hair regrowth circle, a time when hair growth crucially depends on a robust immune privilege around the bulb [47]. Hence, epithelial compartments in the vicinity of the bulge could be possibly exposed to immunoregulatory and/or pro-inflammatory stimuli from the outside, but also the inside, as a result of cross-talk initiated by external factors.
A diversity of environmental, genetic, hormonal, or stress-related triggering factors have been attributed to the development of PCA [35,48,49,50]. The observation that lichenoid inflammation can be triggered is a well-known phenomenon (i.e., isomorphic response or Koebner phenomenon) [51]. However, the contribution of external disruptors of HF homeostasis to the local onset of inflammatory hair diseases has not been deeply studied, although this idea has gained attention due to the rising incidence of frontal fibrosing alopecia (FFA), long considered a lichenoid disease with a peculiar clinical pattern. Links to leave-on facial products, sunscreen use, allergens, and specific foods have been debated [52,53,54], but with no conclusive etiological connection to date [55,56,57].

5. What Do We Know about Bacteria in HF-Associated Disorders and Hair Diseases?

Regarding the contribution of bacteria to disease aggravation and progression, acne vulgaris is a well-studied HF-associated disease entity. Sanford et al. demonstrated how metabolic products of skin-resident bacteria (Cutibacterium acnes, C. acnes) in certain settings can induce inflammatory gene and cytokine expression from sebocytes to promote inflammatory acne [58]. Accordingly, upregulation of inducible antimicrobial peptides such as beta-defensins was demonstrated in lesional and perilesional epithelium of acne biopsies [59]. Interestingly, no differences in relative abundances of C. acnes in patients with acne and healthy subjects were observed, whereas strain population structures were significantly different among the groups [60]. While most studies focus on bacterial abundance, the presence of specific strains or even specific species co-existence might be of relevance.
Hidradenitis suppurativa (HS) is another HF-associated chronic inflammatory skin disease for which triggering microbial factors have been suggested [61,62,63]. Bacteria with biofilm formation capacities, especially coagulase-negative staphylococcus, trigger a cascade of pathogen-associated molecular patterns, leading to inflammasome activation and release of pro-inflammatory cytokines (e.g., interleukin-1β) regulating inflammation, tissue repair, and tissue death [64]. Recently, next-generation sequencing showed that a wider spectrum of species is involved [62]. HS could help us better understand other biofilm-driven diseases, like folliculitis decalvans. Based on the work of Ring et al., where less biofilm structures and less bacteria were found in unaffected axillary skin of HS patients compared to controls [65], we are challenged by homeostasis complexity and the risks of prejudicing high bacterial abundance as a disease causative.
The field is still in the early stages of building a more refined understanding of the role of bacteria in the different alopecia subtypes. Folliculitis decalvans (FD) is probably the best characterized scalp disease concerning bacterial contribution to HF inflammation. Staphylococcus aureus (S. aureus) was isolated from most untreated FD patients, and long-term remission after oral antibiotic treatment has been widely reported [9,66,67,68]. It is hypothesized that cytotoxic proteins secreted by S. aureus act as superantigens and stimulate T cells. In genetically predisposed individuals, innate immunity mechanisms (e.g., IL-8) induce an intense neutrophil migration in the peri- and intra-follicular dermis [69,70], resulting in damage of the follicular epithelium and subsequent release of proinflammatory (IFN-γ, TNF-α) and profibrotic mediators (TGF-β, b-FGF, IL-1β, IL-4) that activate fibroblasts [70]. Presence of S. aureus was found to be enhanced in scalp skin of FD patients and, interestingly, superficial presence in lesional skin increased the chance of lesional subepidermal colonization [71].
However, studies show a variety of HF bacteria in FD patients including C. acnes in biofilm-like structures [12,72], implying the involvement of other bacterial species. Alternatively, it suggests the hypothesis of a follicular reservoir primarily consisting of C. acnes, whose organization in biofilms provides protection and stability, considering that C. acnes is also found in healthy subjects [11,71,73] (Figure 1). How the local microenvironment and signaling across the barrier triggers a shift from a state of immunological tolerance to a state of activation and chronic inflammation are complex.
A good example of how the local follicular microenvironment (e.g., hypoxic conditions, lipid substrates), resident microbes, and their metabolic products can influence inflammatory and antimicrobial processes in the skin is the aforementioned acne vulgaris [58]. Similarly, Folliculitis et perifolliculitis capitis abscedens et suffodiens, a rare chronic inflammatory scalp disease, is considered to be an inflammatory reaction to microbial components of the HF, particularly bacteria (especially C. acnes or S. aureus), yeasts (Malassezia species), and mites (Demodex folliculorum) under certain conditions. The main pathophysiology mechanisms involved are enhanced by an inflammatory bacterial process resulting in chemotaxis of neutrophils [74].
Nevertheless, could other PCA unveil an underlying infection or follicular microbiome alterations? How the HF microbiome possibly preserves IP, and how shifts affect the state of activation and regeneration needs to be explored. Herein, we hypothesize that a dynamic change in the scalp follicular constituents triggers a distinct transcriptional response, alters the local immune system regulations, and activates immune cells, resulting in inflammatory responses, IP collapse, and pathologies like PCA or AA (Figure 2). Whether HF’s regenerative ability is preserved depends on the immune attack localization and the survival of HF stem cells. Microbiome shifts in deeper follicular compartments may attract dense immune peribulbar infiltration (e.g., NK cells observed in AA), potentially causing hair loss but maintaining hair regrowth capacity after inflammation regresses. Our hypothesis is that in PCAs, like lichen planopilaris or FFA, a superficial change in the composition of follicular microbiota could cause a cascade of pro- and inflammatory chemokines around the bulge. This cascade may activate immunological pathways that attract immune cells around this sensitive area, ultimately causing scarring and permanent hair loss.
Dandruff is associated with bacterial and fungal scalp populations [75,76], while recent studies are also focusing on androgenetic alopecia and AA. Micro-inflammation in androgenetic alopecia consists of upper perifollicular infiltrate, suggesting a triggering effect near the infundibulum [77]. A reported improvement after using an antimicrobial lotion indicates the involvement of scalp’s common inhabitants [78]. A recent study by Ho et al. shows alterations in the microbiota of the middle and lower compartments of miniaturized HFs, specifically an increased abundance of C. acnes [79]. Additionally, Malassezia have been shown to have a positive correlation with the incidence of androgenic alopecia [80]. Pinto et al. found a significant increase of C. acnes, accompanied by a decrease of Staphylococcus epidermidis, on the scalp of AA patients [81]. When studying microbiota profiling in diseases, one should also consider whether microbiome shifts represent a causative factor or simply an epiphenomenon secondary to the disease process.
Is the community function of microorganisms directly linked to their relative abundance? How diverse are metabolic pathways and networks within the follicular microenvironment? What effects does crosstalk between protein-coding genes and microbes have? Do environmental triggers affect the functioning and long-term stability of the HF? Now more than ever, technological advances in DNA collection and analysis could provide answers to such questions. Metagenomics represent a strategic concept in achieving a holistic view of the microbial world by investigating three interconnected levels—sample processing, DNA sequencing, and functional analysis [82].

6. A New Era of Microbiome Analyses

Metagenomics, the culture-independent genomic analysis of microbial DNA from environmental samples, allows the analysis of unculturable or previously unknown microbes [83]. Previous decades of research have proven how culturing is the perfect method to learn a lot about a tiny proportion of earth’s microorganisms [83]. Even though culturable bacteria represent less than 1% of the global bacterial species diversity [84], cultures have been the go-to diagnostic method for bacterial infections for decades [83]. Shotgun metagenomics is the non-targeted sequencing of all microbial genomes present in a sample. Combined with new sequencing technologies and computational pipelines, it has transformed recent microbiology research [85]. Even though profiling undescribed microbes is challenging, the reference-genomes produced yearly are quickly increasing (e.g., Human Microbiome Project, Human Microbiome Advanced Project), and accuracy improves as more high-quality metagenomic assemblies become available [85].
Metagenomics data allow taxonomic profiling (describing microbial species abundance) and subtyping of microorganisms according to their strain type [86]. There are two methods for strain level analysis: genotyping and phenotyping, but bacterial phenotypes cannot discriminate between closely related strains. Thus, subtyping of microorganisms shifted to genotyping, i.e., discriminating strains based on their genetic content [87]. Threats to human health underlie the need for strain level identification, e.g., increased virulence and transmissibility or antibiotic resistance of specific strains [88]. Different strains of the same species may have varying effects in the cellular properties of skin cells and were shown to induce variable immune responses to the host [89,90]. For example, different strains of the common human pathogens S. aureus and Streptococcus pyogenes induced acute adaptive immune response of great variability, partly explaining the clinical heterogeneity of infection from the same species among different patients [91].
Functional profiling and the characterization of the metabolic interactions of the microbiome with its human host constitute great potential advantages of sequencing, especially in the understanding of microbe-related diseases. Translated sequence searches against functionally characterized protein families can be used to interpret large metagenomic datasets, including the determination of gene families and pathways absent or present within a community [85,87]. Large metabolic pathway database projects such as the MetaCyc and KEGG, have been under development for years and provide reference pathways that are used to predict the metabolic pathways present in an organism from the annotated genome of that organism [92]. The Human Microbiome Project is a great example of an interdisciplinary world-wide effort to describe and understand the microbial components of human genetics and metabolic landscapes, as well as to elucidate their biological functional roles within their human environment, and how these contribute to physiology and disease [93]. Pipelines like HUMAnN have been further developed to determine the biological functions of these human bacterial communities, and reconstruct their metabolic activities [94].
As we try to identify the essential components of homeostasis and understand the dysfunctions of dysbiosis, biological mechanisms can be explored via novel computational methodologies and technologies that analyze the evolution of microbial communities and their genetic composition, microbe–host interactions, and the effects of external environmental triggers [95]. However, the implementation of these technologies in research or in the clinical and diagnostic routine is not without limitations. In addition to the high cost, there is a scarcity of personnel with the necessary computational training for the analysis of these complex metagenomic datasets. There is also still a lack of standardized computational tools in order to improve the reproducibility of these complex analytical methods.

7. Conclusions

It is not yet clear exactly what changes in the intra- and peri-follicular signaling milieu of alopecia patients, inciting alterations of normal HF- or skin immunology that eventually result in HF damage. It is still unknown whether the hair follicle’s IP collapse is an early stage of the disease pathogenetic process, or a secondary phenomenon as a result of environmental triggers such as dysbiosis. Answering these questions could help focus new therapeutic approaches toward the immune system or the HF unit itself. Various aspects of the microbiome have been correlated to human diseases. Furthermore, some microbiome-centric interventions have shown extraordinary efficacy in the treatment of specific disorders such as recurrent psoriasis, opening new avenues for therapeutic approaches to help reshape the human microbiome toward a healthy status. With this review, we hypothesize a possible connection between the HF microbiome and the pathogenesis of alopecia. We also show the potential of gaining novel knowledge on PCA pathogenesis by moving past culture-dependent approaches in an era of alternative tools, and by merging basic metagenomics approaches with new complementary technologies.

Author Contributions

Conceptualization, A.C. and K.P.-W.; investigation, A.C. and V.K.; resources, U.B.-P., G.M.S. and A.V.; writing—original draft preparation, A.C.; writing—review and editing, V.K., K.P.-W., U.B.-P., G.M.S., and A.V.; visualization, A.C and A.V.; supervision, U.B.-P., G.M.S., and A.V. All authors have read and agreed to the published version of the manuscript.

Funding

We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité—Universitätsmedizin Berlin.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable to this manuscript as no datasets were generated or analyzed for this work.

Acknowledgments

We would like to thank Nathan Shewmon for his English language editorial assistance in preparing this manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chen, Y.E.; Fischbach, M.A.; Belkaid, Y. Skin microbiota-host interactions. Nature 2018, 553, 427–436. [Google Scholar] [CrossRef]
  2. Sender, R.; Fuchs, S.; Milo, R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016, 14, e1002533. [Google Scholar] [CrossRef] [Green Version]
  3. Park, T.; Kim, H.-J.; Myeong, N.R.; Lee, H.G.; Kwack, I.; Lee, J.; Kim, B.J.; Sul, W.J.; An, S. Collapse of human scalp microbiome network in dandruff and seborrhoeic dermatitis. Exp. Dermatol. 2017, 26, 835–838. [Google Scholar] [CrossRef] [Green Version]
  4. Belkaid, Y.; Segre, J.A. Dialogue between skin microbiota and immunity. Science 2014, 346, 954–959. [Google Scholar] [CrossRef]
  5. Oh, J.; Byrd, A.L.; Deming, C.; Conlan, S.; Program, N.C.S.; Kong, H.H.; Segre, J.A. Biogeography and individuality shape function in the human skin metagenome. Nature 2014, 514, 59–64. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Findley, K.; Oh, J.; Yang, J.; Conlan, S.; Deming, C.; Meyer, J.A.; Schoenfeld, D.; Nomicos, E.; Park, M.; Kong, H.H.; et al. Topographic diversity of fungal and bacterial communities in human skin. Nature 2013, 498, 367–370. [Google Scholar] [CrossRef] [PubMed]
  7. Langan, E.A.; Kunstner, A.; Miodovnik, M.; Zillikens, D.; Thaci, D.; Baines, J.F.; Ibrahim, S.M.; Solbach, W.; Knobloch, J.K. Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis. Br. J. Dermatol. 2019, 181, 1254–1264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Francuzik, W.; Franke, K.; Schümann, R.; Heine, G.; Worm, M. Propionibacterium acnes Abundance Correlates Inversely with Staphylococcus aureus: Data from Atopic Dermatitis Skin Microbiome. Acta Derm. Venereol. 2018, 98, 490–495. [Google Scholar] [CrossRef] [Green Version]
  9. Otberg, N.; Kang, H.; Alzolibani, A.A.; Shapiro, J. Folliculitis decalvans. Dermatol. Ther. 2008, 21, 238–244. [Google Scholar] [CrossRef]
  10. Nakatsuji, T.; Chiang, H.-I.; Jiang, S.B.; Nagarajan, H.; Zengler, K.; Gallo, R.L. The microbiome extends to subepidermal compartments of normal skin. Nat. Commun. 2013, 4, 1431. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Watanabe, K.; Nishi, E.; Tashiro, Y.; Sakai, K. Mode and Structure of the Bacterial Community on Human Scalp Hair. Microbes Environ. 2019, 34, 252–259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Matard, B.; Meylheuc, T.; Briandet, R.; Casin, I.; Assouly, P.; Cavelier-Balloy, B.; Reygagne, P. First evidence of bacterial biofilms in the anaerobe part of scalp hair follicles: A pilot comparative study in folliculitis decalvans. J. Eur. Acad. Dermatol. Venereol. 2013, 27, 853–860. [Google Scholar] [CrossRef] [PubMed]
  13. Vogt, A.; Pfannes, E.K.B.; Fimmel, S.; Hadam, S.; Andruck, A.; Kottner, J.; Blume-Peytavi, U. Infundibular protein and RNA microarray analyses from affected and clinically non-affected scalp in male androgenetic alopecia patients. Exp. Dermatol. 2017, 26, 518–521. [Google Scholar] [CrossRef] [Green Version]
  14. Alexeyev, O.A.; Lundskog, B.; Ganceviciene, R.; Palmer, R.H.; McDowell, A.; Patrick, S.; Zouboulis, C.; Golovleva, I. Pattern of tissue invasion by Propionibacterium acnes in acne vulgaris. J. Dermatol. Sci. 2012, 67, 63–66. [Google Scholar] [CrossRef] [PubMed]
  15. O’Neill, A.M.; Gallo, R.L. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome 2018, 6, 177. [Google Scholar] [CrossRef] [PubMed]
  16. Polak-Witka, K.; Constantinou, A.; Schwarzer, R.; Helmuth, J.; Wiessner, A.; Hadam, S.; Kanti, V.; Rancan, F.; Andruck, A.; Richter, C.; et al. Identification of anti-microbial peptides and traces of microbial DNA in infrainfundibular compartments of human scalp terminal hair follicles. Eur. J. Dermatol. 2020. Epub ahead of printing. [Google Scholar] [CrossRef]
  17. Thaiss, C.A.; Levy, M.; Suez, J.; Elinav, E. The interplay between the innate immune system and the microbiota. Curr. Opin. Immunol. 2014, 26, 41–48. [Google Scholar] [CrossRef] [PubMed]
  18. Hooper, L.V.; Littman, D.R.; MacPherson, A.J. Interactions Between the Microbiota and the Immune System. Science 2012, 336, 1268–1273. [Google Scholar] [CrossRef] [Green Version]
  19. Kabashima, K.; Honda, T.; Ginhoux, F.; Egawa, G. The immunological anatomy of the skin. Nat. Rev. Immunol. 2019, 19, 19–30. [Google Scholar] [CrossRef]
  20. Adachi, T.; Kobayashi, T.; Sugihara, E.; Yamada, T.; Ikuta, K.; Pittaluga, S.; Saya, H.; Amagai, M.; Nagao, K. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat. Med. 2015, 21, 1272–1279. [Google Scholar] [CrossRef]
  21. Chen, X.; Niyonsaba, F.; Ushio, H.; Okuda, D.; Nagaoka, I.; Ikeda, S.; Okumura, K.; Ogawa, H. Synergistic effect of antibacterial agents human β-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. 2005, 40, 123–132. [Google Scholar] [CrossRef]
  22. Vogt, A.; Mahé, B.; Costagliola, D.; Bonduelle, O.; Hadam, S.; Schaefer, G.; Schaefer, H.; Katlama, C.; Sterry, W.; Autran, B.; et al. Transcutaneous Anti-Influenza Vaccination Promotes Both CD4 and CD8 T Cell Immune Responses in Humans. J. Immunol. 2008, 180, 1482–1489. [Google Scholar] [CrossRef] [Green Version]
  23. Vogt, A.; Combadiere, B.; Hadam, S.; Stieler, K.M.; Lademann, J.; Schaefer, H.; Autran, B.; Sterry, W.; Blume-Peytavi, U. 40 nm, but not 750 or 1500 nm, Nanoparticles Enter Epidermal CD1a+ Cells after Transcutaneous Application on Human Skin. J. Investig. Dermatol. 2006, 126, 1316–1322. [Google Scholar] [CrossRef] [Green Version]
  24. Scharschmidt, T.C.; Vasquez, K.S.; Pauli, M.L.; Leitner, E.G.; Chu, K.; Truong, H.-A.; Lowe, M.M.; Rodriguez, R.S.; Ali, N.; Laszik, Z.G.; et al. Commensal Microbes and Hair Follicle Morphogenesis Coordinately Drive Treg Migration into Neonatal Skin. Cell Host Microbe 2017, 21, 467–477. [Google Scholar] [CrossRef] [Green Version]
  25. Chen, C.-C.; Wang, L.; Plikus, M.V.; Jiang, T.X.; Murray, P.J.; Ramos, R.; Guerrero-Juarez, C.F.; Hughes, M.W.; Lee, O.K.; Shi, S.; et al. Organ-Level Quorum Sensing Directs Regeneration in Hair Stem Cell Populations. Cell 2015, 161, 277–290. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Ali, N.; Zirak, B.; Rodriguez, R.S.; Pauli, M.L.; Truong, H.-A.; Lai, K.; Ahn, R.; Corbin, K.; Lowe, M.M.; Scharschmidt, T.C.; et al. Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation. Cell 2017, 169, 1119–1129. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Kobayashi, T.; Voisin, B.; Kim, D.Y.; Kennedy, E.A.; Jo, J.-H.; Shih, H.-Y.; Truong, A.; Doebel, T.; Sakamoto, K.; Cui, C.-Y.; et al. Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium. Cell 2019, 176, 982–997. [Google Scholar] [CrossRef] [Green Version]
  28. Wahl, S.M.; Wen, J.; Moutsopoulos, N. TGF-beta: A mobile purveyor of immune privilege. Immunol. Rev. 2006, 213, 213–227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Ichiryu, N.; Fairchild, P.J. Immune Privilege of Stem Cells. Methods Mol. Biol. 2013, 1029, 1–16. [Google Scholar] [CrossRef] [PubMed]
  30. Ito, T.; Ito, N.; Saatoff, M.; Hashizume, H.; Fukamizu, H.; Nickoloff, B.J.; Takigawa, M.; Paus, R. Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack. J. Investig. Dermatol. 2008, 128, 1196–1206. [Google Scholar] [CrossRef]
  31. Ito, T.; Ito, N.; Bettermann, A.; Tokura, Y.; Takigawa, M.; Paus, R. Collapse and Restoration of MHC Class-I-Dependent Immune Privilege: Exploiting the human hair follicle as a model. Am. J. Pathol. 2004, 164, 623–634. [Google Scholar] [CrossRef] [Green Version]
  32. Paus, R.; Nickoloff, B.J.; Ito, T. A “hairy privilege”. Trends Immunol. 2005, 26, 32–40. [Google Scholar] [CrossRef] [PubMed]
  33. Paus, R.; Eichmüller, S.; Hofmann, U.; Czarnetzki, B.M.; Robinson, P. Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br. J. Dermatol. 1994, 131, 177–183. [Google Scholar] [CrossRef] [PubMed]
  34. Westgate, G.E.; Craggs, R.I.; Gibson, W.T. Immune Privilege in Hair Growth. J. Investig. Dermatol. 1991, 97, 417–420. [Google Scholar] [CrossRef] [Green Version]
  35. Harries, M.J.; Paus, R. The Pathogenesis of Primary Cicatricial Alopecias. Am. J. Pathol. 2010, 177, 2152–2162. [Google Scholar] [CrossRef]
  36. Bröcker, E.-B.; Echternacht-Happle, K.; Hamm, H.; Happle, R. Abnormal Expression of Class I and Class II Major Histocompatibility Antigens in Alopecia Areata: Modulation by Topical Immunotherapy. J. Investig. Dermatol. 1987, 88, 564–568. [Google Scholar] [CrossRef] [Green Version]
  37. Paus, R.; Bulfone-Paus, S.; Bertolini, M. Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management. J. Investig. Dermatol. Symp. Proc. 2018, 19, S12–S17. [Google Scholar] [CrossRef] [Green Version]
  38. Meyer, K.C.; Klatte, J.E.; Dinh, H.V.; Harries, M.J.; Reithmayer, K.; Meyer, W.; Sinclair, R.; Paus, R. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br. J. Dermatol. 2008, 159, 1077–1085. [Google Scholar] [CrossRef] [PubMed]
  39. Rosenblum, M.D.; Olasz, E.B.; Yancey, K.B.; Woodliff, J.E.; Lazarova, Z.; Gerber, K.A.; Truitt, R.L. Expression of CD200 on Epithelial Cells of the Murine Hair Follicle: A Role in Tissue-Specific Immune Tolerance? J. Investig. Dermatol. 2004, 123, 880–887. [Google Scholar] [CrossRef] [Green Version]
  40. Harries, M.J.; Jimenez, F.; Izeta, A.; Hardman, J.; Panicker, S.P.; Poblet, E.; Paus, R. Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases. Trends Mol. Med. 2018, 24, 435–448. [Google Scholar] [CrossRef] [PubMed]
  41. Ohyama, M. Primary cicatricial alopecia: Recent advances in understanding and management. J. Dermatol. 2012, 39, 18–26. [Google Scholar] [CrossRef]
  42. Christoph, T.; Müller-Röver, S.; Audring, H.; Tobin, D.J.; Hermes, B.; Cotsarelis, G.; Rückert, R.; Paus, R. The human hair follicle immune system: Cellular composition and immune privilege. Br. J. Dermatol. 2000, 142, 862–873. [Google Scholar] [CrossRef]
  43. Sun, K.-L.; Chang, J.-M. Special types of folliculitis which should be differentiated from acne. Dermato Endocrinol. 2017, 9, e1356519. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Mahe, B.; Vogt, A.; Liard, C.; Duffy, D.; Abadie, V.; Bonduelle, O.; Boissonnas, A.; Sterry, W.; Verrier, B.; Blume-Peytavi, U.; et al. Nanoparticle-Based Targeting of Vaccine Compounds to Skin Antigen-Presenting Cells by Hair Follicles and their Transport in Mice. J. Investig. Dermatol. 2009, 129, 1156–1164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Combadière, B.; Vogt, A.; Mahé, B.; Costagliola, D.; Hadam, S.; Bonduelle, O.; Sterry, W.; Staszewski, S.; Schaefer, H.; Van Der Werf, S.; et al. Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial. PLoS ONE 2010, 5, e10818. [Google Scholar] [CrossRef]
  46. Li, L.; Lishko, V.; Hoffman, R.M. Liposome targeting of high molecular weight DNA to the hair follicles of histocultured skin: A model for gene therapy of the hair growth processes. In Vitro Cell. Dev. Biol. Anim. 1993, 29, 258–260. [Google Scholar] [CrossRef]
  47. Vogt, A.; Constantinou, A.; Rancan, F.; Ghoreschi, K.; Blume-Peytavi, U.; Combadiere, B. A niche in the spotlight: Could external factors critically disturb hair follicle homeostasis and contribute to inflammatory hair follicle diseases? Exp. Dermatol. 2020, 29, 1080–1087. [Google Scholar] [CrossRef] [PubMed]
  48. Tziotzios, C.; Petridis, C.; Dand, N.; Ainali, C.; Saklatvala, J.R.; Pullabhatla, V.; Onoufriadis, A.; Pramanik, R.; Baudry, D.; Lee, S.H.; et al. Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02. Nat. Commun. 2019, 10, 1150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Azzawi, S.; Penzi, L.R.; Senna, M.M. Immune Privilege Collapse and Alopecia Development: Is Stress a Factor. Skin Appendage Disord. 2018, 4, 236–244. [Google Scholar] [CrossRef] [Green Version]
  50. Moreno-Arrones, O.M.; Saceda-Corralo, D.; Rodrigues-Barata, A.R.; Castellanos-Gonzalez, M.; Pugnaire, M.A.; Grimalt, R.; Hermosa-Gelbard, A.; Bernardez, C.; Molina-Ruiz, A.M.; Ormaechea-Perez, N.; et al. Risk factors associated with frontal fi-brosing alopecia: A multicentre case-control study. Clin. Exp. Dermatol. 2018, 44, 404–410. [Google Scholar] [CrossRef]
  51. Diani, M.; Cozzi, C.; Altomare, G. Heinrich Koebner and His Phenomenon. JAMA Dermatol. 2016, 152, 919. [Google Scholar] [CrossRef] [Green Version]
  52. Aldoori, N.; Dobson, K.; Holden, C.R.; McDonagh, A.J.; Harries, M.; Messenger, A.G. Frontal fibrosing alopecia: Possible association with leave-on facial skin care products and sunscreens; a questionnaire study. Br. J. Dermatol. 2016, 175, 762–767. [Google Scholar] [CrossRef]
  53. Callander, J.; Frost, J.; Stone, N. Ultraviolet filters in hair-care products: A possible link with frontal fibrosing alopecia and lichen planopilaris. Clin. Exp. Dermatol. 2018, 43, 69–70. [Google Scholar] [CrossRef] [PubMed]
  54. Rudnicka, L.; Rakowska, A. The increasing incidence of frontal fibrosing alopecia. In search of triggering factors. J. Eur. Acad. Dermatol. Venereol. 2017, 31, 1579–1580. [Google Scholar] [CrossRef] [Green Version]
  55. Kanti, V.; Constantinou, A.; Reygagne, P.; Vogt, A.; Kottner, J.; Blume-Peytavi, U. Frontal fibrosing alopecia: Demographic and clinical characteristics of 490 cases. J. Eur. Acad. Dermatol. Venereol. 2019, 33, 1976–1983. [Google Scholar] [CrossRef]
  56. Felmingham, C.; Yip, L.; Tam, M.; Nixon, R.L. Allergy to sunscreen and leave-on facial products is not a likely causative mechanism in frontal fibrosing alopecia: Perspective from contact allergy experts. Br. J. Dermatol. 2019, 182, 481–482. [Google Scholar] [CrossRef] [PubMed]
  57. Seegobin, S.D.; Tziotzios, C.; Stefanato, C.M.; Bhargava, K.; Fenton, D.A.; McGrath, J.A. Frontal fibrosing alopecia: There is no statistically significant association with leave-on facial skin care products and sunscreens. Br. J. Dermatol. 2016, 175, 1407–1408. [Google Scholar] [CrossRef] [PubMed]
  58. Sanford, J.A.; O’Neill, A.M.; Zouboulis, C.C.; Gallo, R.L. Short-Chain Fatty Acids fromCutibacterium acnesActivate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes. J. Immunol. 2019, 202, 1767–1776. [Google Scholar] [CrossRef] [Green Version]
  59. Chronnell, C.M.; Ghali, L.R.; Ali, R.S.; Quinn, A.G.; Holland, D.B.; Bull, J.J.; Cunliffe, W.J.; McKay, I.A.; Philpott, M.P.; Müller-Röver, S. Human β Defensin-1 and -2 Expression in Human Pilosebaceous Units: Upregulation in Acne Vulgaris Lesions. J. Investig. Dermatol. 2001, 117, 1120–1125. [Google Scholar] [CrossRef] [Green Version]
  60. Fitz-Gibbon, S.; Tomida, S.; Chiu, B.-H.; Nguyen, L.; Du, C.; Liu, M.; Elashoff, D.; Erfe, M.C.; Loncaric, A.; Kim, J.; et al. Propionibacterium acnes Strain Populations in the Human Skin Microbiome Associated with Acne. J. Investig. Dermatol. 2013, 133, 2152–2160. [Google Scholar] [CrossRef] [Green Version]
  61. Von Laffert, M.; Helmbold, P.; Wohlrab, J.; Fiedler, E.; Stadie, V.; Marsch, W.C. Hidradenitis suppurativa (acne inversa): Early inflammatory events at terminal follicles and at interfollicular epidermis. Exp. Dermatol. 2010, 19, 533–537. [Google Scholar] [CrossRef]
  62. Ring, H.C.; Thorsen, J.; Saunte, D.M.; Lilje, B.; Bay, L.; Riis, P.T.; Larsen, N.; Andersen, L.O.; Nielsen, H.V.; Miller, I.M.; et al. The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls. JAMA Dermatol. 2017, 153, 897–905. [Google Scholar] [CrossRef] [PubMed]
  63. Guet-Revillet, H.; Jais, J.-P.; Ungeheuer, M.-N.; Coignard-Biehler, H.; Duchatelet, S.; Delage, M.; Lam, T.; Hovnanian, A.; Lortholary, O.; Nassif, X.; et al. The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study. Clin. Infect. Dis. 2017, 65, 282–291. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Vekic, D.A.; Frew, J.; Cains, G.D. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1. Australas. J. Dermatol. 2018, 59, 267–277. [Google Scholar] [CrossRef]
  65. Ring, H.C.; Bay, L.; Kallenbach, K.; Miller, I.M.; Prens, E.; Saunte, D.M.; Bjarnsholt, T.; Jemec, G.B. Normal Skin Microbiota is Altered in Pre-clinical Hidradenitis Suppurativa. Acta Derm. Venereol. 2017, 97, 208–213. [Google Scholar] [CrossRef] [Green Version]
  66. Annessi, G. Tufted folliculitis of the scalp: A distinctive clinicohistological variant of folliculitis decalvans. Br. J. Dermatol. 1998, 138, 799–805. [Google Scholar] [CrossRef] [PubMed]
  67. Brooke, R.C.C.; Griffiths, C.E.M. Folliculitis decalvans. Clin. Exp. Dermatol. 2001, 26, 120–122. [Google Scholar] [CrossRef] [PubMed]
  68. Sillani, C.; Bin, Z.; Ying, Z.; Zeming, C.; Jian, Y.; Xingqi, Z. Effective treatment of folliculitis decalvans using selected antimicrobial agents. Int. J. Trichol. 2010, 2, 20–23. [Google Scholar] [CrossRef] [Green Version]
  69. Powell, J.J.; Dawber, R.P.; Gatter, K. Folliculitis decalvans including tufted folliculitis: Clinical, histological and therapeutic findings. Br. J. Dermatol. 1999, 140, 328–333. [Google Scholar] [CrossRef] [PubMed]
  70. Chiarini, C.; Torchia, D.; Bianchi, B.; Volpi, W.; Caproni, M.; Fabbri, P. Immunopathogenesis of Folliculitis Decalvans: Clues in early lesions. Am. J. Clin. Pathol. 2008, 130, 526–534. [Google Scholar] [CrossRef] [Green Version]
  71. Matard, B.; Donay, J.L.; Resche-Rigon, M.; Tristan, A.; Farhi, D.; Rousseau, C.; Mercier-Delarue, S.; Cavelier–Balloy, B.; Assouly, P.; Petit, A.; et al. Folliculitis decalvans is characterized by a persistent, abnormal subepidermal microbiota. Exp. Dermatol. 2019, 29, 295–298. [Google Scholar] [CrossRef] [PubMed]
  72. Jahns, A.C.; Lundskog, B.; Nosek, D.; Killasli, H.; Emtestam, L.; Alexeyev, O.A. Microbiology of folliculitis decalvans: A histological study of 37 patients. J. Eur. Acad. Dermatol. Venereol. 2015, 29, 1025–1026. [Google Scholar] [CrossRef] [PubMed]
  73. Jahns, A.C.; Alexeyev, O.A. Three dimensional distribution of Propionibacterium acnes biofilms in human skin. Exp. Dermatol. 2014, 23, 687–689. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Tchernev, G. Folliculitis et perifolliculitis capitis abscedens et suffodiens controlled with a combination therapy: Systemic antibiosis (Metronidazole Plus Clindamycin), dermatosurgical approach, and high-dose isotretinoin. Indian J. Dermatol. 2011, 56, 318–320. [Google Scholar] [CrossRef]
  75. Xu, Z.; Wang, Z.; Yuan, C.; Liu, X.; Yang, F.; Wang, T.; Wang, J.; Manabe, K.; Qin, O.; Wang, X.; et al. Dandruff is associated with the conjoined interactions between host and microorganisms. Sci. Rep. 2016, 6, 24877. [Google Scholar] [CrossRef] [Green Version]
  76. Clavaud, C.; Jourdain, R.; Bar-Hen, A.; Tichit, M.; Bouchier, C.; Pouradier, F.; El Rawadi, C.; Guillot, J.; Ménard-Szczebara, F.; Breton, L.; et al. Dandruff Is Associated with Disequilibrium in the Proportion of the Major Bacterial and Fungal Populations Colonizing the Scalp. PLoS ONE 2013, 8, e58203. [Google Scholar] [CrossRef]
  77. Mahe, Y.F.; Michelet, J.-F.; Billoni, N.; Jarrousse, F.; Buan, B.; Commo, S.; Saint-Leger, D.; Bernard, B.A. Androgenetic alopecia and microinflammation. Int. J. Dermatol. 2000, 39, 576–584. [Google Scholar] [CrossRef]
  78. Piérard, G.; Piérard-Franchimont, C.; Nikkels-Tassoudji, N.; Nikkels, A.; Saint Léger, D. Improvement in the inflammatory aspect of androgenetic alopecia. A pilot study with an antimicrobial lotion. J. Dermatol. Treat. 1996, 7, 153–157. [Google Scholar] [CrossRef]
  79. Ho, B.S.-Y.; Ho, E.X.P.; Chu, C.W.; Ramasamy, S.; Bigliardi-Qi, M.; De Sessions, P.F.; Bigliardi, P.L. Microbiome in the hair follicle of androgenetic alopecia patients. PLoS ONE 2019, 14, e0216330. [Google Scholar] [CrossRef] [PubMed]
  80. Huang, J.; Ran, Y.; Pradhan, S.; Yan, W.; Dai, Y. Investigation on Microecology of Hair Root Fungi in Androgenetic Alopecia Patients. Mycopathologia 2019, 184, 505–515. [Google Scholar] [CrossRef]
  81. Pinto, D.; Sorbellini, E.; Marzani, B.; Rucco, M.; Giuliani, G.; Rinaldi, F. Scalp bacterial shift in Alopecia areata. PLoS ONE 2019, 14, e0215206. [Google Scholar] [CrossRef] [Green Version]
  82. Guazzaroni, M.-E.; Beloqui, A.; Golyshin, P.N.; Ferrer, M. Metagenomics as a new technological tool to gain scientific knowledge. World J. Microbiol. Biotechnol. 2009, 25, 945–954. [Google Scholar] [CrossRef]
  83. Handelsman, J.; Rondon, M.R.; Brady, S.F.; Clardy, J.; Goodman, R.M. Molecular biological access to the chemistry of unknown soil microbes: A new frontier for natural products. Chem. Biol. 1998, 5, R245–R249. [Google Scholar] [CrossRef] [Green Version]
  84. Yang, D.; Chertov, O.; Oppenheim, J.J.; Bykovskaia, S.N.; Chen, Q.; Buffo, M.J.; Shogan, J.; Anderson, M.; Schröder, J.M.; Wang, J.M.; et al. β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6. Science 1999, 286, 525–528. [Google Scholar] [CrossRef] [PubMed]
  85. Quince, C.; Walker, A.W.; Simpson, J.T.; Loman, N.J.; Segata, N. Shotgun metagenomics, from sampling to analysis. Nat. Biotechnol. 2017, 35, 833–844. [Google Scholar] [CrossRef] [Green Version]
  86. MacCannell, D. Bacterial Strain Typing. Clin. Lab. Med. 2013, 33, 629–650. [Google Scholar] [CrossRef]
  87. Li, W.; Raoult, D.; Fournier, P.-E. Bacterial strain typing in the genomic era. FEMS Microbiol. Rev. 2009, 33, 892–916. [Google Scholar] [CrossRef] [Green Version]
  88. Fournier, P.-E.; Zhu, Y.; Ogata, H.; Raoult, D. Use of Highly Variable Intergenic Spacer Sequences for Multispacer Typing of Rickettsia conorii Strains. J. Clin. Microbiol. 2004, 42, 5757–5766. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  89. Nagy, I.; Pivarcsi, A.; Koreck, A.; Széll, M.; Urbán, E.; Kemény, L. Distinct Strains of Propionibacterium acnes Induce Selective Human β-Defensin-2 and Interleukin-8 Expression in Human Keratinocytes Through Toll-Like Receptors. J. Investig. Dermatol. 2005, 124, 931–938. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  90. Tax, G.; Urbán, E.; Palotás, Z.; Puskás, R.; Kónya, Z.; Bíró, T.; Kemény, L.; Szabó, K. Propionic Acid Produced by Propionibacterium acnes Strains Contri-butes to Their Pathogenicity. Acta Derm. Venereol. 2016, 96, 43–49. [Google Scholar] [CrossRef] [Green Version]
  91. Sela, U.; Euler, C.W.; Da Rosa, J.C.; Fischetti, V.A. Strains of bacterial species induce a greatly varied acute adaptive immune response: The contribution of the accessory genome. PLoS Pathog. 2018, 14, e1006726. [Google Scholar] [CrossRef] [PubMed]
  92. Caspi, R.; Billington, R.; Keseler, I.M.; Kothari, A.; Krummenacker, M.; Midford, P.E.; Ong, W.K.; Paley, S.; Subhraveti, P.; Karp, P.D. The MetaCyc database of metabolic pathways and enzymes—A 2019 update. Nucleic Acids Res. 2020, 48, D445–D453. [Google Scholar] [CrossRef] [Green Version]
  93. Turnbaugh, P.J.; Ley, R.E.; Hamady, M.; Fraser-Liggett, C.M.; Knight, R.; Gordon, J.I. The Human Microbiome Project. Nature 2007, 449, 804–810. [Google Scholar] [CrossRef] [PubMed]
  94. Abubucker, S.; Segata, N.; Goll, J.; Schubert, A.M.; Izard, J.; Cantarel, B.L.; Rodriguez-Mueller, B.; Zucker, J.; Thiagarajan, M.; Henrissat, B.; et al. Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome. PLoS Comput. Biol. 2012, 8, e1002358. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Dovrolis, N.; Kolios, G.; Spyrou, G.M.; Maroulakou, I. Computational profiling of the gut-brain axis: Microflora dysbiosis insights to neurological disorders. Brief. Bioinform. 2019, 20, 825–841. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Need for a deeper understanding of HF microbiome. Images of Visia-CR Porphyrins Analysis in scalp diseases. Porphyrins, Cutibacterium acnes excretions, fluoresce in UV light and exhibit circular bright spot characteristics. Porphyrins are more numerous on the lesional scalp of folliculitis decalvans patients and scarce on frontal fibrosing alopecia patients. Yet, there is reason to believe that events of greater complexity which are crucial for HF health and disease take place deeper. Diving deeper into bacterial communities and interactions with the HF’s epithelial lining may help unlock the secrets of regulatory processes along the HF, revealing essential information for the quest of the missing links between follicular microbiome and disease. Images from left to right, Standard White Light Image (Normal Clinical Photograph); Coproporphyrin (CpIII) Fluorescence Image and Protoporphyrin (PpIX) Fluorescence Image of the scalp surface (follicular openings and the interfollicular area). Green and red fluorescence spots correspond to CpIII and PpIX respectively. HF, hair follicle.
Figure 1. Need for a deeper understanding of HF microbiome. Images of Visia-CR Porphyrins Analysis in scalp diseases. Porphyrins, Cutibacterium acnes excretions, fluoresce in UV light and exhibit circular bright spot characteristics. Porphyrins are more numerous on the lesional scalp of folliculitis decalvans patients and scarce on frontal fibrosing alopecia patients. Yet, there is reason to believe that events of greater complexity which are crucial for HF health and disease take place deeper. Diving deeper into bacterial communities and interactions with the HF’s epithelial lining may help unlock the secrets of regulatory processes along the HF, revealing essential information for the quest of the missing links between follicular microbiome and disease. Images from left to right, Standard White Light Image (Normal Clinical Photograph); Coproporphyrin (CpIII) Fluorescence Image and Protoporphyrin (PpIX) Fluorescence Image of the scalp surface (follicular openings and the interfollicular area). Green and red fluorescence spots correspond to CpIII and PpIX respectively. HF, hair follicle.
Biomedicines 09 00236 g001
Figure 2. Our hypothesis. The effect of the microbiome on HF stem cell niche protection and survival. The skin surface and follicular openings are recognized sites of rich microbial colonization and intense immune activation, with cross-talk across the skin barrier. The bacterial microbiome extends below the infundibulum, with the confirmed presence of various species and high abundance of Corynebacterium and Staphylococcus. It is in close proximity to structures of the immune privileged status, which are essential for the hair cycle. Several preliminary studies suggest that external stimuli could affect the state of activation of the HF immune system. Lower sections of the HF are protected from immune cell infiltration under healthy conditions, the so-called “immune-privileged” areas. This includes the bulge, where a stem cell niche is found, and the bulb, where cells divide and grow to build the new hair. However, both regions are sites of intense inflammatory infiltrate in inflammatory hair diseases like primary cicatricial alopecia and alopecia areata. Alterations in the HF microbiome or the penetration depth of microbial material could be related to homeostasis, modulation of cutaneous immune reactions, and inflammatory processes along the HF. The localization of this involvement with the immune system is critical, affecting the possibility of regrowth after subsidence of inflammation. When the stem cell niche is attacked, like in cicatricial alopecia, patients suffer permanent, scarring hair loss. On the other hand, AA pathogenesis involves inflammation of the peribulbar region, allowing a possible hair regrowth. The role of microbiota in the pathogenesis of alopecia is proposed, but in ways more complex than just bacterial abundance of specific species in the area. HF, hair follicle.
Figure 2. Our hypothesis. The effect of the microbiome on HF stem cell niche protection and survival. The skin surface and follicular openings are recognized sites of rich microbial colonization and intense immune activation, with cross-talk across the skin barrier. The bacterial microbiome extends below the infundibulum, with the confirmed presence of various species and high abundance of Corynebacterium and Staphylococcus. It is in close proximity to structures of the immune privileged status, which are essential for the hair cycle. Several preliminary studies suggest that external stimuli could affect the state of activation of the HF immune system. Lower sections of the HF are protected from immune cell infiltration under healthy conditions, the so-called “immune-privileged” areas. This includes the bulge, where a stem cell niche is found, and the bulb, where cells divide and grow to build the new hair. However, both regions are sites of intense inflammatory infiltrate in inflammatory hair diseases like primary cicatricial alopecia and alopecia areata. Alterations in the HF microbiome or the penetration depth of microbial material could be related to homeostasis, modulation of cutaneous immune reactions, and inflammatory processes along the HF. The localization of this involvement with the immune system is critical, affecting the possibility of regrowth after subsidence of inflammation. When the stem cell niche is attacked, like in cicatricial alopecia, patients suffer permanent, scarring hair loss. On the other hand, AA pathogenesis involves inflammation of the peribulbar region, allowing a possible hair regrowth. The role of microbiota in the pathogenesis of alopecia is proposed, but in ways more complex than just bacterial abundance of specific species in the area. HF, hair follicle.
Biomedicines 09 00236 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Constantinou, A.; Kanti, V.; Polak-Witka, K.; Blume-Peytavi, U.; Spyrou, G.M.; Vogt, A. The Potential Relevance of the Microbiome to Hair Physiology and Regeneration: The Emerging Role of Metagenomics. Biomedicines 2021, 9, 236. https://0-doi-org.brum.beds.ac.uk/10.3390/biomedicines9030236

AMA Style

Constantinou A, Kanti V, Polak-Witka K, Blume-Peytavi U, Spyrou GM, Vogt A. The Potential Relevance of the Microbiome to Hair Physiology and Regeneration: The Emerging Role of Metagenomics. Biomedicines. 2021; 9(3):236. https://0-doi-org.brum.beds.ac.uk/10.3390/biomedicines9030236

Chicago/Turabian Style

Constantinou, Andria, Varvara Kanti, Katarzyna Polak-Witka, Ulrike Blume-Peytavi, George M. Spyrou, and Annika Vogt. 2021. "The Potential Relevance of the Microbiome to Hair Physiology and Regeneration: The Emerging Role of Metagenomics" Biomedicines 9, no. 3: 236. https://0-doi-org.brum.beds.ac.uk/10.3390/biomedicines9030236

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop